A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial (Q73218411)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1999

Language	Label	Description	Also known as
English	A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial	scientific article published on 01 August 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

phase III clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

D Ball

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Bishop

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P O'Brien

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Davis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Ryan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I Olver

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Q Walker

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Joseph

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Radiotherapy and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

129-136

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900093-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0167-8140(99)00093-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10577698%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73218411&oldid=1754297820"